162 related articles for article (PubMed ID: 30022447)
1. CD147 (EMMPRIN) controls malignant properties of breast cancer cells by interdependent signaling of Wnt and JAK/STAT pathways.
Knutti N; Huber O; Friedrich K
Mol Cell Biochem; 2019 Jan; 451(1-2):197-209. PubMed ID: 30022447
[TBL] [Abstract][Full Text] [Related]
2. Soluble extracellular matrix metalloproteinase inducer (EMMPRIN, EMN) regulates cancer-related cellular functions by homotypic interactions with surface CD147.
Knutti N; Kuepper M; Friedrich K
FEBS J; 2015 Nov; 282(21):4187-200. PubMed ID: 26277583
[TBL] [Abstract][Full Text] [Related]
3. Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.
Schlange T; Matsuda Y; Lienhard S; Huber A; Hynes NE
Breast Cancer Res; 2007; 9(5):R63. PubMed ID: 17897439
[TBL] [Abstract][Full Text] [Related]
4. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
[TBL] [Abstract][Full Text] [Related]
5. β-Estradiol-dependent activation of the JAK/STAT pathway requires p/CIP and CARM1.
Coughlan N; Thillainadesan G; Andrews J; Isovic M; Torchia J
Biochim Biophys Acta; 2013 Jun; 1833(6):1463-75. PubMed ID: 23434684
[TBL] [Abstract][Full Text] [Related]
6. Extracellular matrix metalloproteinase inducer (CD147) confers resistance of breast cancer cells to Anoikis through inhibition of Bim.
Yang JM; O'Neill P; Jin W; Foty R; Medina DJ; Xu Z; Lomas M; Arndt GM; Tang Y; Nakada M; Yan L; Hait WN
J Biol Chem; 2006 Apr; 281(14):9719-27. PubMed ID: 16443928
[TBL] [Abstract][Full Text] [Related]
7. LINC00669 insulates the JAK/STAT suppressor SOCS1 to promote nasopharyngeal cancer cell proliferation and invasion.
Qing X; Tan GL; Liu HW; Li W; Ai JG; Xiong SS; Yang MQ; Wang TS
J Exp Clin Cancer Res; 2020 Aug; 39(1):166. PubMed ID: 32831137
[TBL] [Abstract][Full Text] [Related]
8. Lycopene synergistically enhances quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC.
Preet R; Mohapatra P; Das D; Satapathy SR; Choudhuri T; Wyatt MD; Kundu CN
Carcinogenesis; 2013 Feb; 34(2):277-86. PubMed ID: 23129580
[TBL] [Abstract][Full Text] [Related]
9. EMILIN2 down-modulates the Wnt signalling pathway and suppresses breast cancer cell growth and migration.
Marastoni S; Andreuzzi E; Paulitti A; Colladel R; Pellicani R; Todaro F; Schiavinato A; Bonaldo P; Colombatti A; Mongiat M
J Pathol; 2014 Mar; 232(4):391-404. PubMed ID: 24374807
[TBL] [Abstract][Full Text] [Related]
10. EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion.
Farabegoli F; Govoni M; Spisni E; Papi A
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28465354
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway.
Jiang Q; He M; Guan S; Ma M; Wu H; Yu Z; Jiang L; Wang Y; Zong X; Jin F; Wei M
Tumour Biol; 2016 Apr; 37(4):5001-11. PubMed ID: 26537584
[TBL] [Abstract][Full Text] [Related]
12. c-Myb Enhances Breast Cancer Invasion and Metastasis through the Wnt/β-Catenin/Axin2 Pathway.
Li Y; Jin K; van Pelt GW; van Dam H; Yu X; Mesker WE; Ten Dijke P; Zhou F; Zhang L
Cancer Res; 2016 Jun; 76(11):3364-75. PubMed ID: 27197202
[TBL] [Abstract][Full Text] [Related]
13. MiR-34a Inhibits Breast Cancer Proliferation and Progression by Targeting Wnt1 in Wnt/β-Catenin Signaling Pathway.
Si W; Li Y; Shao H; Hu R; Wang W; Zhang K; Yang Q
Am J Med Sci; 2016 Aug; 352(2):191-9. PubMed ID: 27524218
[TBL] [Abstract][Full Text] [Related]
14. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.
Farabegoli F; Papi A; Orlandi M
Biosci Rep; 2011 Apr; 31(2):99-108. PubMed ID: 20446926
[TBL] [Abstract][Full Text] [Related]
15. Silencing of Wnt-1 by siRNA induces apoptosis of MCF-7 human breast cancer cells.
Wieczorek M; Paczkowska A; Guzenda P; Majorek M; Bednarek AK; Lamparska-Przybysz M
Cancer Biol Ther; 2008 Feb; 7(2):268-74. PubMed ID: 18059186
[TBL] [Abstract][Full Text] [Related]
16. Lentivirus mediated RNA interference of EMMPRIN (CD147) gene inhibits the proliferation, matrigel invasion and tumor formation of breast cancer cells.
Yang J; Wang R; Li H; Lv Q; Meng W; Yang X
Cancer Biomark; 2016 Jul; 17(2):237-47. PubMed ID: 27434292
[TBL] [Abstract][Full Text] [Related]
17. Novel effects of sphingosylphosphorylcholine on invasion of breast cancer: Involvement of matrix metalloproteinase-3 secretion leading to WNT activation.
Kim HJ; Kang GJ; Kim EJ; Park MK; Byun HJ; Nam S; Lee H; Lee CH
Biochim Biophys Acta; 2016 Sep; 1862(9):1533-43. PubMed ID: 27216977
[TBL] [Abstract][Full Text] [Related]
18. RNA interference targeting CD147 inhibits metastasis and invasion of human breast cancer MCF-7 cells by downregulating MMP-9/VEGF expression.
Li F; Zhang J; Guo J; Jia Y; Han Y; Wang Z
Acta Biochim Biophys Sin (Shanghai); 2018 Jul; 50(7):676-684. PubMed ID: 29901696
[TBL] [Abstract][Full Text] [Related]
19. CD147, CD44, and the epidermal growth factor receptor (EGFR) signaling pathway cooperate to regulate breast epithelial cell invasiveness.
Grass GD; Tolliver LB; Bratoeva M; Toole BP
J Biol Chem; 2013 Sep; 288(36):26089-26104. PubMed ID: 23888049
[TBL] [Abstract][Full Text] [Related]
20. Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer.
Johnson RW; Merkel AR; Page JM; Ruppender NS; Guelcher SA; Sterling JA
Clin Exp Metastasis; 2014 Dec; 31(8):945-59. PubMed ID: 25359619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
